NID-2 study group Investigators

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

R. Torella, R. Marfella, L. Zirpoli, 2022, Cardiovascular Diabetology.